medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2021, Number 2

<< Back Next >>

Rev Mex Urol 2021; 81 (2)

The current paradigm of diabetic cystopathy in Mexico

Lira-Moreno G, Serrano S, Hernández-León O, Castellanos H

Language: Spanish
References: 21
Page: 1-11
PDF size: 169.07 Kb.


ABSTRACT

The term diabetic cystopathy is attributed to the deterioration of detrusor function caused by a combination of myogenic and neurogenic mechanisms, resulting in an increase in postmicturition residual bladder volume capacity and alteration, accompanied by reduced bladder contraction and sensation, in diabetic patients. The disease primarily originates from sensory and autonomic neuropathy due to alterations in the bladder nerve fibers. Clinical presentation is insidious, and when a symptom, usually urinary incontinence, does appear, the disease is in an advanced stage. Diagnosis is made through clinical presentation, associated with neurologic symptomatology, and confirmed through urodynamic studies. Strict control of diabetes mellitus, with treatment adherence, is essential for preventing complications in the long term, such as diabetic cystopathy. Once the disease is diagnosed, treatment can be pharmacologic, with a wide variety of drugs to choose from, and/or surgical, such as bladder denervation or myomectomy.


REFERENCES

  1. Liu G, Daneshgari F. Diabetic Bladder Dysfunction. Chinese medical journal. 2014;127:1357–64. doi: 10.3760/ cma.j.issn.0366-6999.20132407

  2. Oger-Roussel S, Behr-Roussel D, Caisey S, Kergoat M, Charon C, Audet A, et al. Bladder and erectile dysfunctions in the Type 2 diabetic Goto-Kakizaki rat. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2013;306(2):R108– 17. doi: 10.1152/ajpregu.00033.2013

  3. Gomez CS, Kanagarajah P, Gousse AE. Bladder dysfunction in patients with diabetes. Curr Urol Rep. 2011;12(6):419–26. doi: 10.1007/s11934- 011-0214-0

  4. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103(2):137–49. doi: 10.1016/j. diabres.2013.11.002

  5. Institute for Health Metrics and Evaluation. GBD Compare 2016. Washington, D.C: University of Washington; 2017.

  6. Instituto Nacional de Estadística y Geografía. Comunicado de prensa núm 525/18. Mexico; 2018.

  7. Arrellano-Valdez F, Urrutia-Osorio M, Arroyo C, Soto-Vega E. A comprehensive review of urologic complications in patients with diabetes. Springerplus. 2014;3:549. doi: 10.1186/2193- 1801-3-549

  8. Lin Tl, Chen Gd, Chen Yc, Huang Cn, Ng Sc. Aging and recurrent urinary tract infections are associated with bladder dysfunction in type 2 diabetes. Taiwan J Obstet Gynecol. 2012;51(3):381–6. doi: 10.1016/j. tjog.2012.07.011

  9. Karoli R, Bhat S, Fatima J, Priya S. A study of bladder dysfunction in women with type 2 diabetes mellitus. Indian J Endocrinol Metab. 2014;18(4):552–7. doi: 10.4103/2230- 8210.137518

  10. Burakgazi AZ, Alsowaity B, Burakgazi ZA, Unal D, Kelly JJ. Bladder dysfunction in peripheral neuropathies. Muscle Nerve. 2012;45(1):2–8. doi: 10.1002/mus.22178

  11. Dixon JS, Gosling JA. Histology and fine structure of the muscularis mucosae of the human urinary bladder. J Anat. 1983;136(Pt 2):265–71.

  12. de Groat WC, Yoshimura N. Mechanisms underlying the recovery of lower urinary tract function following spinal cord injury. Weaver LC, Polosa C, editors. Progress in Brain Research. 2006; 152:59–84. doi: 10.1016/ S0079-6123(05)52005-3

  13. Morrison J, Birder L, Craggs M. Control neural. In: Incontinencia. Reino Unido: Health Publication Ltd; 2005.

  14. Fowler CJ, Griffiths D, de Groat WC. The neural control of micturition. Nat Rev Neurosci. 2008 Jun;9(6):453–66. doi: 10.1038/nrn2401

  15. Thor KB, de Groat WC. Neural control of the female urethral and anal rhabdosphincters and pelvic floor muscles. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2010;299(2):R416– 38. doi: 10.1152/ajpregu.00111.2010

  16. Golabek T, Kiely E, O’Reilly B. Detrusor overactivity in diabetic and non-diabetic patients: is there a difference? International braz j urol. 2012;38(5):652–60. doi: 10.1590/S1677- 55382012000500010

  17. Hanna-Mitchell AT, Ruiz GW, Daneshgari F, Liu G, Apodaca G, Birder LA. Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R84-93. doi: 10.1152/ ajpregu.00129.2012

  18. Xiao N, Wang Z, Huang Y, Daneshgari F, Liu G. Roles of Polyuria and Hyperglycemia on Bladder Dysfunction in Diabetes. J Urol. 2013;189(3):1130–6. doi: 10.1016/j. juro.2012.08.222

  19. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):167–78. doi: 10.1002/nau.10052

  20. van Waalwijk van Doorn E, Anders K, Khullar V, Kulseng-Hanssen S, Pesce F, Robertson A, et al. Standardisation of ambulatory urodynamic monitoring: Report of the Standardisation Sub- Committee of the International Continence Society for Ambulatory Urodynamic Studies. Neurourol Urodyn. 2000;19(2):113–25. doi: 10.1002/(sici)1520-6777(2000)19:2<113::aidnau2> 3.0.co;2-#

  21. Panigrahy R, Singh B, Das SK. Diabetic uropathy and bladder dysfunctions. Diabetes Metab Syndr. 2017;11(1):81–2. doi: 10.1016/j. dsx.2016.06.018




2020     |     www.medigraphic.com